Old National Bancorp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
10,467
+236
+2% +$31.1K 0.03% 263
2026
Q1
$1.43M Buy
10,231
+1
+0% +$140 0.02% 278
2025
Q4
$1.26M Buy
10,230
+15
+0.1% +$1.82K 0.02% 288
2025
Q3
$1.13M Sell
10,215
-489
-5% -$55.6K 0.02% 297
2025
Q2
$1.19M Sell
10,704
-1,326
-11% -$141K 0.02% 289
2025
Q1
$1.35M Sell
12,030
-5,365
-31% -$554K 0.04% 231
2024
Q4
$1.61M Buy
17,395
+857
+5% +$77.2K 0.04% 234
2024
Q3
$1.39M Sell
16,538
-2,613
-14% -$199K 0.03% 257
2024
Q2
$1.31M Sell
19,151
-2,153
-10% -$144K 0.03% 254
2024
Q1
$1.56M Sell
21,304
-1,414
-6% -$109K 0.04% 244
2023
Q4
$1.84M Sell
22,718
-802
-3% -$62.4K 0.05% 224
2023
Q3
$1.76M Sell
23,520
-637
-3% -$49K 0.05% 220
2023
Q2
$1.86M Buy
24,157
+237
+1% +$18.9K 0.05% 229
2023
Q1
$1.98M Buy
23,920
+1,686
+8% +$140K 0.06% 226
2022
Q4
$1.91M Sell
22,234
-76
-0.3% -$6.02K 0.06% 237
2022
Q3
$1.38M Buy
22,310
+1,209
+6% +$76.2K 0.05% 262
2022
Q2
$1.3M Buy
21,101
+14,775
+234% +$915K 0.04% 262
2022
Q1
$376K Buy
6,326
+85
+1% +$5.43K 0.01% 391
2021
Q4
$453K Sell
6,241
-177
-3% -$12.2K 0.02% 350
2021
Q3
$449K Buy
6,418
+195
+3% +$13.7K 0.02% 358
2021
Q2
$429K Sell
6,223
-11,308
-65% -$755K 0.02% 369
2021
Q1
$1.13M Sell
17,531
-2
-0% -$129 0.05% 244
2020
Q4
$1.02M Sell
17,533
-200
-1% -$12.1K 0.04% 247
2020
Q3
$1.12M Sell
17,733
-1,106
-6% -$76.7K 0.05% 224
2020
Q2
$1.45M Sell
18,839
-128
-0.7% -$9.81K 0.07% 195
2020
Q1
$1.42M Sell
18,967
-1,199
-6% -$82.8K 0.09% 185
2019
Q4
$1.31M Buy
20,166
+666
+3% +$43.4K 0.06% 209
2019
Q3
$1.24M Sell
19,500
-1,630
-8% -$107K 0.06% 219
2019
Q2
$1.43M Sell
21,130
-5,010
-19% -$330K 0.07% 204
2019
Q1
$1.7M Sell
26,140
-3,869
-13% -$257K 0.09% 186
2018
Q4
$1.88M Buy
30,009
+1,274
+4% +$89K 0.1% 171
2018
Q3
$2.22M Sell
28,735
-706
-2% -$53.3K 0.11% 172
2018
Q2
$2.09M Sell
29,441
-342
-1% -$24.2K 0.11% 173
2018
Q1
$2.25M Buy
29,783
+313
+1% +$24.9K 0.12% 165
2017
Q4
$2.11M Sell
29,470
-2,622
-8% -$199K 0.11% 163
2017
Q3
$2.6M Buy
32,092
+4,561
+17% +$349K 0.14% 137
2017
Q2
$1.95M Buy
27,531
+3,940
+17% +$262K 0.11% 159
2017
Q1
$1.6M Sell
23,591
-371
-2% -$26.1K 0.09% 180
2016
Q4
$1.72M Sell
23,962
-116
-0.5% -$8.62K 0.1% 166
2016
Q3
$1.91M Buy
24,078
+3,035
+14% +$247K 0.11% 145
2016
Q2
$1.76M Sell
21,043
-94
-0.4% -$8.34K 0.1% 156
2016
Q1
$1.94M Sell
21,137
-1,026
-5% -$92.5K 0.11% 138
2015
Q4
$2.24M Buy
22,163
+1,919
+9% +$200K 0.13% 124
2015
Q3
$1.99M Sell
20,244
-8,426
-29% -$936K 0.12% 139
2015
Q2
$3.36M Sell
28,670
-3,532
-11% -$386K 0.19% 107
2015
Q1
$3.16M Sell
32,202
-1,688
-5% -$171K 0.17% 114
2014
Q4
$3.19M Sell
33,890
-2,159
-6% -$223K 0.2% 94
2014
Q3
$3.84M Buy
36,049
+2,743
+8% +$269K 0.25% 87
2014
Q2
$2.76M Buy
33,306
+1,340
+4% +$104K 0.21% 86
2014
Q1
$2.27M Buy
31,966
+13,580
+74% +$1.07M 0.21% 69
2013
Q4
$1.38M Buy
+18,386
New +$1.28M 0.13% 79

Other funds holding GILD

Old National Bancorp's GILD Position: Q2 2026 in Review

Old National Bancorp increased its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, buying an estimated $31.1K and bringing the position to 10,467 shares worth $1.32M. The position accounts for 0.03% of the portfolio, ranked #263.

Old National Bancorp first reported a position in GILD in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.84M in Q3 2014. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Old National Bancorp held 10,467 shares of Gilead Sciences worth $1.32M as of Q2 2026.
  • Old National Bancorp bought 236 Gilead Sciences shares in Q2 2026, an estimated $31.1K.
  • Gilead Sciences made up 0.03% of Old National Bancorp's portfolio in Q2 2026, its #263 holding.
  • Old National Bancorp first reported a position in Gilead Sciences in Q4 2013 and has held it in 51 quarters since.
  • Old National Bancorp's Gilead Sciences position peaked at $3.84M in Q3 2014.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.